Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Director departure Appointed director
|
Skye Bioscience, Inc. (NMUS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/22/2023 |
4
| Schwab Andrew J. (10% Owner) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 267,602,039 shares
@ $0 Granted 10,558,878 shares
@ $0 Granted 684,361,447 shares
@ $0.0103, valued at
$7M
Granted 161,944,872 shares
@ $0.0103, valued at
$1.7M
Granted 6,389,921 shares
@ $0.0103, valued at
$65.8k
Granted 426,348,120 warrants
@ $0.0206, valued at
$8.8M
|
|
03/17/2023 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 16,641,486 shares
@ $0.017, valued at
$282.9k
Granted 41,379,164 shares
@ $0.0386, valued at
$1.6M
Acquired 9,141,486 warrants
@ $0.151, valued at
$1.4M
Disposed/sold 9,141,486 warrants
@ $0.017, valued at
$155.4k
Bought 2,500,000 options to buy
@ $0.0386, valued at
$96.5k
Disposed/sold 2,500,000 options to buy
@ $0.0386, valued at
$96.5k
|
|
01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 250,000 options to buy
@ $0.017, valued at
$4.3k
|
|
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2021 |
4
| DHILLON PUNIT (CEO) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 2,000,000 shares
@ $0 Granted 3,090,000 options to buy
@ $0.058, valued at
$179.2k
|
|
12/16/2021 |
4
| Arsenault Kaitlyn Melanie (CFO) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 1,000,000 shares
@ $0 Granted 1,770,000 options to buy
@ $0.058, valued at
$102.7k
|
|
12/16/2021 |
4
| Ward Keith Wayne (Director) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 250,000 options to buy
@ $0.058, valued at
$14.5k
|
|
10/05/2021 |
4
| Arsenault Kaitlyn Melanie (CFO) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 1,600,000 options to buy
@ $0.09, valued at
$144k
|
|
09/16/2021 |
4
| DALESANDRO MARGARET (Director) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 150,000 options to buy
@ $0.12, valued at
$18k
|
|
09/16/2021 |
4
| HEPPELL JAMES L (Director) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 150,000 options to buy
@ $0.12, valued at
$18k
|
|
09/16/2021 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on Skye Bioscience, Inc.
Txns:
| Granted 25,000 options to buy
@ $0.12, valued at
$3k
|
|
08/12/2020 |
4
| DALESANDRO MARGARET (Director) has filed a Form 4 on Emerald Bioscience, Inc.
Txns:
| Granted 250,000 options to buy
@ $0.045, valued at
$11.3k
|
|
08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2020 |
4
| HEPPELL JAMES L (Director) has filed a Form 4 on Emerald Bioscience, Inc.
Txns:
| Bought 500,000 shares
@ $50000, valued at
$25000M
Granted 1,000,000 options to buy
@ $0.045, valued at
$45k
|
|
08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/28/2020 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Emerald Bioscience, Inc.
Txns:
| Acquired 40,800,000 shares
@ $4080000, valued at
$166464000M
Disposed of 40,800,000 options to buy
@ $0.1, valued at
$4.1M
Disposed of 4,080,000 options to buy
@ $0.4, valued at
$1.6M
|
|
08/23/2019 |
4
| KIM DENNIS D (Chief Medical Officer) has filed a Form 4 on Emerald Bioscience, Inc.
Txns:
| Granted 736,541 options to buy
@ $0.3, valued at
$221k
|
|
04/01/2019 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Emerald Bioscience, Inc.
Txns:
| Acquired 2,000,000 options to buy
@ $0.4, valued at
$800k
Acquired 2,500,000 warrants
@ $0.5, valued at
$1.3M
|
|
02/01/2019 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Nemus Bioscience, Inc.
Txns:
| Acquired options to buy
@ $0.4, valued at
$0 Acquired 2,500,000 warrants
@ $0.5, valued at
$1.3M
|
|
12/28/2018 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Nemus Bioscience, Inc.
Txns:
| Acquired 37,667 shares
@ $0 |
|
11/01/2018 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Nemus Bioscience, Inc.
Txns:
| Acquired options to buy
@ $0.4, valued at
$0 Acquired 2,500,000 warrants
@ $0.5, valued at
$1.3M
|
|
10/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/12/2018 |
4
| HEPPELL JAMES L (Director) has filed a Form 4 on Nemus Bioscience, Inc.
Txns:
| Granted 200,000 options to buy
@ $0.305, valued at
$61k
|
|
10/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/23/2018 |
4
| Cesario Douglas A (CFO and Secretary) has filed a Form 4 on Nemus Bioscience, Inc.
Txns:
| Granted 643,501 shares
@ $0 Granted 1,195,073 options to buy
@ $0.245, valued at
$292.8k
|
|
04/03/2018 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Nemus Bioscience, Inc.
Txns:
| Converted 12,335,000 shares
@ $0.1, valued at
$1.2M
Converted 20,000,000 shares
@ $0.1, valued at
$2M
Converted 1,234 convertible preferred
@ $0.1, valued at
$123.4 Converted 2,000 convertible preferred
@ $0.1, valued at
$200 |
|
03/02/2018 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Nemus Bioscience, Inc.
Txns:
| Exercised (in-or-at-the-money) 1,781,250 warrants
@ $0.001, valued at
$1.8k
|
|
02/21/2018 |
4
| Emerald Health Sciences Inc. (10% Owner) has filed a Form 4 on Nemus Bioscience, Inc.
Txns:
| Bought 15,000,000 shares
@ $0 Bought 20,400,000 warrants
@ $0.1, valued at
$2M
|
|
|
|
|